BRCA2 anticorps
Aperçu rapide pour BRCA2 anticorps (ABIN7234156)
Antigène
Voir toutes BRCA2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Antigen Affinity Purification
-
Immunogène
- Recombinant Human Breast cancer type 2 susceptibility protein
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:1000-1:3000 IHC 1:100-1:200 IF 1:100-1:400
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.05 % Proclin300 and 50 % glycerol, pH 7.4.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
-
Autre désignation
- BRCA2
-
Sujet
- Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele.
-
Poids moléculaire
-
Observed_MW: 384 kDa
Calculated_MW: 384 kDa
-
UniProt
- P51587
-
Pathways
- Réparation de l'ADN, M Phase, Maintenance of Protein Location
Antigène
-